SEC EDGAR · Financial report
JNJ: 10-Q financial filing
Filed 10-Q for an event or period dated 2026-09-27. Read the company report for its disclosures.
Follow JNJ- Became public
- Oct 21, 2026, 4:18 PM EDT
- Event / period date
- Sep 27, 2026
- Collected
- Nov 7, 2026, 10:06 PM EST
Why this is connected
This filing identifies JOHNSON & JOHNSON as the issuer of the security. The company's SEC identifier connects it to JNJ.
Source evidence
Read the source excerpt or record
jnj-20260927 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended September 27, 2026 or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission file number 1-3215 Johnson & Johnson (Exact name of registrant as specified in its charter) New Jersey 22-1024240 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) One Johnson & Johnson Plaza New Brunswick , New Jersey 08933 (Address of principal executive offices) Registrant’s telephone number, including area code ( 732 ) 524-0400 Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☑ Yes ☐ No Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☑ Yes ☐ No Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. Large accelerated filer ☑ Accelerated filer ☐
Congressional trading in JNJ
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- Oct 30, 2026$1K–$15K
Rep. Thomas H. Kean, Jr. (R-NJ-7)
Sold (partial) Johnson & Johnson JNJ
$1K–$15K · Traded Sep 30, 2026 · disclosed Oct 30, 2026
Committee overlap: Energy and CommerceTraded 13 days before earnings - Oct 7, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Sep 25, 2026 · disclosed Oct 7, 2026 · Spouse
- Oct 7, 2026$15K–$50K
Rep. Ro Khanna (D-CA-17)
$15K–$50K · Traded Sep 4, 2026 · disclosed Oct 7, 2026 · Spouse
- Oct 5, 2026$1K–$15K
Rep. Lloyd Doggett (D-TX-37)
$1K–$15K · Traded Sep 8, 2026 · disclosed Oct 5, 2026
- Sep 12, 2026$1K–$15K
Rep. Thomas H. Kean, Jr. (R-NJ-7)
Sold (partial) Johnson & Johnson JNJ
$1K–$15K · Traded Aug 27, 2026 · disclosed Sep 12, 2026
Committee overlap: Energy and Commerce - Sep 11, 2026$1K–$15K
Sen. John Boozman (R-AR)
Sold (partial) Johnson & Johnson JNJ
$1K–$15K · Traded Aug 20, 2026 · disclosed Sep 11, 2026 · Joint
- Aug 14, 2026$1K–$15K
Rep. Richard McCormick (R-GA-7)
$1K–$15K · Traded Jul 30, 2026 · disclosed Aug 14, 2026
- Jul 21, 2026$1K–$15K
Sen. Alan Armstrong (R-OK)
$1K–$15K · Traded Mar 30, 2026 · disclosed Jul 21, 2026 · filed 113 days later
Committee overlap: HELP
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.